Dengue Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Dengue Treatment Market by Drug Class (NSAIDS, Antibiotics, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Dengue Treatment Market Introduction:

Dengue fever is also known as break bone fever is mosquito born and endemic disease that leads to severe flu like illness. Dengue caused by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by several species of mosquitos of the Aedes type, principally A. aegypti. Symptoms of dengue include fever, headache vomiting, muscle and joint pains, and characteristic skin rash. On infection of dengue, patient will automatically recover within seven days. But in some cases, it may develop to life threatening dengue hemorrhagic fever. The virus has five different types of strains, infection with one strain usually gives lifelong immunity to that type. Subsequent infection with a different type of dengue virus increases the risk of severe complications.

 

Market Dynamics: Dengue Treatment Market

Global dengue treatment market anticipated surging its growth owing to rise in dengue burden in tropical and sub-tropical regions, increased government funding to fight against dengue, and unmet market needs of managing dengue burden around the world. In addition, market players keen interest in uplift the market by partnerships, promising dengue pipelines and rise in medical insurance in developing countries is anticipated to drive the market furthermore. However, lack or insufficient healthcare infrastructure in underdeveloped and developing regions leading to serious medical conditions going unnoticed. Furthermore, lack of awareness related to symptoms and the high-cost of treatment are hindering the dengue-treatment market.

 

Market Segmentation: Dengue Treatment Market

Dengue Treatment Market has been segmented on the basis of drug class and distribution channel

 

Based on drug class, Global Market is segmented into

  • NSAIDS
  • Antibiotics
  • Corticosteroids

 

Based on distribution channel, Global Market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

 

Global Market overview:

Dengue Treatment market is expected to grow at a significant rate during forecast period. According to World Health Organization (WHO) estimates, 50 to 100 Mn infections occur annually, including 500,000 DHF cases and 22,000 deaths, mostly among children. Dengue treatment market is at developing stage. Market players collaborating to other companies or research institutions for the development of drugs for treating the dengue. For instance, in August 2013, Johnson and Johnson Services Inc. collaborated with biotechnology nonprofit organization The Wellcome Trust, for the development of prevention and treatment therapies for dengue fever.

 

Regional Overview: Dengue Treatment Market

Geographically Dengue Treatment Market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East &Africa. Latin America market expected to grow owing to increased dengue cases. According to WHO, in 2010, 1.6 million cases of dengue were reported in the Americas alone. In Asia-Pacific region, dengue treatment market expected to grow at a high rate due to increase in dengue coupled with an increase in government funding for dengue prevention and treatment. Market players in Asia are actively participating in develepment of dengue treating drugs to increase their market share. For instance, in May 2016, Sun Pharma collaborated with International Centre of Genetic Engineering and Biotechnology (ICGEB) to develep drug for treatment of dengue. South East Asia and Western Pacific regions are more seriously affected by dengue. Hence, companies are planning to launch their vaccines in South East Asia regions.

 

Market Participants: Dengue Treatment Market

Some of the market players in Dengue treatment market include F. Hoffmann-La Roche AG (Switzerland), Sun Pharmaceutical Industries Limited  (India), Abbivax (France), Takeda Pharmaceutical Company Ltd (Japan), Merck & Co Inc. (U.S.), and VABIOTECH (Vietnam) to name a few.

 

Key Market Developments: Dengue Treatment Market

In September 2017, Abbivax and Evotec AG entered into strategic partnership to develop novel antiviral agents including dengue virus, influenza and others.

 

 Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

Description

Dengue Treatment Market Introduction:

Dengue fever is also known as break bone fever is mosquito born and endemic disease that leads to severe flu like illness. Dengue caused by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by several species of mosquitos of the Aedes type, principally A. aegypti. Symptoms of dengue include fever, headache vomiting, muscle and joint pains, and characteristic skin rash. On infection of dengue, patient will automatically recover within seven days. But in some cases, it may develop to life threatening dengue hemorrhagic fever. The virus has five different types of strains, infection with one strain usually gives lifelong immunity to that type. Subsequent infection with a different type of dengue virus increases the risk of severe complications.

 

Market Dynamics: Dengue Treatment Market

Global dengue treatment market anticipated surging its growth owing to rise in dengue burden in tropical and sub-tropical regions, increased government funding to fight against dengue, and unmet market needs of managing dengue burden around the world. In addition, market players keen interest in uplift the market by partnerships, promising dengue pipelines and rise in medical insurance in developing countries is anticipated to drive the market furthermore. However, lack or insufficient healthcare infrastructure in underdeveloped and developing regions leading to serious medical conditions going unnoticed. Furthermore, lack of awareness related to symptoms and the high-cost of treatment are hindering the dengue-treatment market.

 

Market Segmentation: Dengue Treatment Market

Dengue Treatment Market has been segmented on the basis of drug class and distribution channel

 

Based on drug class, Global Market is segmented into

  • NSAIDS
  • Antibiotics
  • Corticosteroids

 

Based on distribution channel, Global Market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

 

Global Market overview:

Dengue Treatment market is expected to grow at a significant rate during forecast period. According to World Health Organization (WHO) estimates, 50 to 100 Mn infections occur annually, including 500,000 DHF cases and 22,000 deaths, mostly among children. Dengue treatment market is at developing stage. Market players collaborating to other companies or research institutions for the development of drugs for treating the dengue. For instance, in August 2013, Johnson and Johnson Services Inc. collaborated with biotechnology nonprofit organization The Wellcome Trust, for the development of prevention and treatment therapies for dengue fever.

 

Regional Overview: Dengue Treatment Market

Geographically Dengue Treatment Market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East &Africa. Latin America market expected to grow owing to increased dengue cases. According to WHO, in 2010, 1.6 million cases of dengue were reported in the Americas alone. In Asia-Pacific region, dengue treatment market expected to grow at a high rate due to increase in dengue coupled with an increase in government funding for dengue prevention and treatment. Market players in Asia are actively participating in develepment of dengue treating drugs to increase their market share. For instance, in May 2016, Sun Pharma collaborated with International Centre of Genetic Engineering and Biotechnology (ICGEB) to develep drug for treatment of dengue. South East Asia and Western Pacific regions are more seriously affected by dengue. Hence, companies are planning to launch their vaccines in South East Asia regions.

 

Market Participants: Dengue Treatment Market

Some of the market players in Dengue treatment market include F. Hoffmann-La Roche AG (Switzerland), Sun Pharmaceutical Industries Limited  (India), Abbivax (France), Takeda Pharmaceutical Company Ltd (Japan), Merck & Co Inc. (U.S.), and VABIOTECH (Vietnam) to name a few.

 

Key Market Developments: Dengue Treatment Market

In September 2017, Abbivax and Evotec AG entered into strategic partnership to develop novel antiviral agents including dengue virus, influenza and others.

 

 Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX